Bharat Parenterals Limited Q1 FY27 results deck summary

Results deck of 5 Aug 2026, summarised by AI from the filing.

Consolidated revenue ₹93.7 cr (19.2% YoY decline) with EBITDA ₹8.5 cr; FY27 guidance maintained across entities.

Key takeaways

1. Risk Innoxel EBITDA still negative at ₹(1.8) cr; break-even not yet reached.

Original filing on BSE

Bharat Parenterals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (5 Aug 2026)
• Q4 FY26: Earnings call (19 May 2026), Results deck (18 May 2026)
• Q3 FY26: Results deck (30 Jan 2026)
• Q2 FY26: Earnings call (12 Nov 2025), Results deck (12 Nov 2025)
• Q1 FY26: Results deck (28 Jul 2025)
• Q4 FY25: Earnings call (14 May 2025)